Structural basis of μ-opioid receptor targeting by a nanobody antagonist

86

Structural basis of μ-opioid receptor targeting by a nanobody antagonist

Tags:

Previous Article

How Chlamydia manipulate the host cell

Tiny antibodies to fight the dangerous effects of opioids

Related Posts

Accumulation of succinate suppresses de novo purine synthesis through succinylation-mediated control of the mitochondrial folate cycle

Accumulation of succinate suppresses de novo purine syn...

57

Specific and redundant roles for Gli2 and Gli3 in establishing cell fate during murine hair follicle development

Specific and redundant roles for Gli2 and Gli3 in estab...

44

Associations of epigenetic aging and COVID‐ 19: A 3‐year longitudinal study

Associations of epigenetic aging and COVID‐ 19: A 3‐yea...

134